Learn which applications are most common and more from our latest PCR survey results

Allows the most comprehensive validation of oncology gene panels and large-scale exome sequencing assays

New solution empowers scientists to precisely evaluate the efficiency of their experiment in less time and at lower cost than with any other method

GeneStrat is a genomic liquid biopsy test utilizing circulating tumor nucleic acids from plasma that is used by physicians to inform treatment of patients with non-small cell lung cancer

Learn readers’ liquid handling purchasing plans and more from our latest survey results.

Tanuja Koppal, PhD discusses regular versus digital PCR with Drs. Emir Hodzic, Keith R. Jerome, and Ruth Hall Sedlak.

Digital PCR (dPCR) is a gene amplification method particularly suited to detecting and quantifying rare genes.

Stephen Bustin, PhD talks about the persisting problem of lack of transparency and reliability in current PCR data.

Since its introduction in 2011, Bio-Rad Laboratory’s Droplet Digital PCR (ddPCR™) technology has demonstrated the potential to be a transformative technology, particularly in clinical applications. At the second annual CHI Digital PCR Conference in San Diego, CA, Oct. 7–9, 2013, 12 scientists using Bio-Rad’s Droplet Digital PCR systems will highlight ddPCR applications that have advanced their research.

Basic research and clinical research labs have long relied on real-time PCR (qPCR) for its speed, sensitivity, specificity and ease-of-use. Common applications include gene expression analysis, mutation detection and identification of copy number variation to better understand inherited disorders, cancer and infectious disease.